Prostaglandin E2 is variably induced by bacteriol superantigens in bovine mononuclear cells and has a regulatory role for the T cell proliferative response

Immunobiology

Volumn 201, Issue 5, 2000, Pages 493-505

  Hendricks, Anke ^a   Leibold, Wolfgang ^a   Kaever, Volkhard ^b   Schuberth, H Joachim ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INDOMETACIN; PROSTAGLANDIN E2; SUPERANTIGEN; ENTEROTOXIN; ENTEROTOXIN A, STAPHYLOCOCCAL; ENTEROTOXIN B, STAPHYLOCOCCAL; PROSTAGLANDIN E; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; CATTLE; CONTROLLED STUDY; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN INDUCTION; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; METABOLISM; STAPHYLOCOCCUS AUREUS; TIME;

ANIMALS; ANTIGENS, BACTERIAL; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYCLOOXYGENASE INHIBITORS; ENTEROTOXINS; FLOW CYTOMETRY; INDOMETHACIN; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; PROSTAGLANDINS E; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; TIME FACTORS;

EID: 0033625509     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(00)80069-8     Document Type: Article

References (44)

1. + cells to bacterial superantigens. Eur. J. Immunol. 22: 1935.
2. CROW, M. K., G. ZAGON, Z. CHU, B. RAVINA, J. R. TUMANG, B. C. COLE, and S. M. FRIEDMAN. 1992. Human B cell differentiation induced by microbial superantigens: unselected peripheral blood lymphocytes secrete polyclonal immunoglobulin in response to Mycoplasma arthritidis mitogen. Autoimmunity 14: 23.
3. HENDRICKS, A. 1998. Functional characterisation of the interaction between bacterial super-antigens and bovine MHC class II molecules. Thesis, School of Veterinary Medicine, Hannover.
4. SCHUBERTH, H.-J., A. HENDRICKS, and W. LEIBOLD. 1998. There is no regulatory role for induced nitric oxide in the regulation of the in vitro proliferative response of bovine mononuclear cells to mitogens, alloantigens or superantigens. Immunobiol. 198: 439.
5. ANTONELLI, G., A. MASTINO, P. AMICUCCI, O. TURRIZIANI, C. FAVALLI, and E. GARACI. 1990. Mechanism of production of interferon-gamma: role of arachidonic acid metabolites. J. Biol. Regul. Homeost. Agents 4: 13.
6. OLSEN, S. C., D. ATLURU, S. ATLURU, D. S. MCVEY, and H. H. ERICKSON. 1992. Inhibition of equine mononuclear cell proliferation and leukotriene B4 synthesis by a specific 5-lipoxygenase inhibitor, A-63162. Am. J. Vet. Res. 53: 1015.
7. MASTINO, A., S. GRELLI, M. PIACENTINI, S. OLIVERIO, C. FAVALLI, C. F. PERNO, and E. GARCI. 1993. Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV. Cell. Immunol. 152: 120.
8. SNIJDEWINT, F. G. M., P. KALINSKI, E. A. WIERENGA, J. D. BOS, and M. L. KAPSENBERG. 1993. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150: 5321.
9. HAYEK, M. G., S. N. MEYDANI, M. MEYDANI, and J. B. BLUMBERG. 1994. Age differences in eicosanoid production of mouse splenocytes: effects on mitogen-induced T cell proliferation. J. Gerontol.49: 197.
10. SECOMBES, C. J., K. CLEMENTS, I. ASHTON, and A. F. ROWLEY. 1994. The effect of eicosanoids on rainbow trout, Oncorhynchus mykiss, leucocyte proliferation. Vet. Immunol. Immunopathol. 42: 367.
11. PICA, F., O. FRANZESE, C. D'ONOFRIO, E. BONMASSAR, C. FAVALLI, and E. GARACI. 1996. Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway. J. Pharmacol. Exp. Ther. 277: 1793.
12. ROPER, R. L., and R. P. PHIPPS. 1992. Prostaglandin E2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis. J. Immunol. 149: 2984.
13. ANASTASSIOU, E. D., F. PALIOGIANNI, J. P. BALOW, H. YAMADA, and D. T. BOUMPAS. 1992. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels. J. Immunol. 148: 2845.
14. +) B cells. Activated peritoneal macrophages release prostaglandin E2, which inhibits IgM secretion by peritoneal B-1a cells. J. Immunol. 154:5630.
15. KOMATSU, H., H. YAJU, K. CHIBA, and T. OKUMOTO. 1991. Inhibition by cyclooxygenase inhibitors of intcrleukin-6 production by human peripheral blood mononuclear cells. Int. J. Immunopharmacol. 13: 1137.
16. DONNELY, R. P., and T. J. ROGERS. 1983. Inhibitors of prostaglandin synthesis block the induction of staphylococcal enterotoxin B-activated T-suppressor cells. Cell. Immunol. 81: 61.
17. MEHINDATE, K., R. AL-DACCAK, J. M. DAYER, B. P. KENNEDY, C. KRIS, P. BORGEAT, P. E. POUBELLE, and W. MOURAD. 1995. Superantigen-induced collagenase gene expression in human IFN-gamma-treated fibroblast-like synobiocytes involves prostaglandin E2. Evidence for a role of cyclooxygenase-2 and cytosolic phospholipase A2. J. Immunol. 155: 3570.
18. NAESSENS, J., and J. HOPKINS. 1996. Introduction and summary of workshop findings. Vet. Immunol. Immunopathol. 52: 213.
19. PECHHOLD, K., T. POHL, and D. KABELITZ. 1994. Rapid quantification of lymphocyte subsets in heterogeneous cell populations by flow cytometry. Cytometry 16: 152.
20. SCHUBERTH, H. J., I. ANDERS, U. PAPE, and W. LEIBOLD. 1992. One-dimensional isoelectric focusing and immunoblotting of equine major histocompatibility complex class 1 antigens. Anim. Genet. 23: 87.
21. BRODIE, C., J. DOMENICO, and E. W. GELFAND. 1994. Ethanol inhibits early events in T-lymphocyte activation. Clin. Immunol. Immunopathol. 70: 129.
22. CHIAPPELLI, F., M. KUNG, P. LEE, L. PHAM, E. MANFRINI, and P. VILLANUEVA. 1995. Alcohol modulation of human normal T cell activation, maturation, and migration. Alcohol. Clin. Exp. Res. 19: 539.
23. SZABO, G., P. MANDREKAR, and D. CATALANO. 1995. inhibition of superantigen-induced T cell proliferation and monocyte IL-1 beta, TNF-alpha, and IL-6 production by acute ethanol treatment. J. Leukoc. Biol. 58: 342.
24. YU, C. L., C. L., LIU, C. Y. TSAI, K. H. SUN, T. S. LIAO, W. M. LIN, H. L. CHEN, and H. S. YU. 1993. Prostaglandin E2 suppresses phytohemagglutinin-induced immune responses of normal human mononuclear cells by decreasing intracellular glutathione generation, but not due to increased DNA strand breaks or apoptosis. Agents Actions 40: 191.
25. FERNANDES, G., B. CHANDRASEKAR, X. LUAN, and D. A. TROYER. 1996. Modulation of antioxidant enzymes and programmed cell death by n-3 fatty acids. Lipids 31 (Suppl): 91.
26. 2 production. J. Surg. Res. 51: 66.
27. STOUT, R. D., K. P. FERGUSON, Y. N. LI, and D. W. LAMBE. 1992. Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production. Infect. Immun. 60: 922.
28. 2 but not IL-1 beta in patients with adult periodontitis. J. periodontal Res. 24: 88.
29. BOALE, T., V. LANCASTER, R. HUNT, P. GEMSKI, and M. JETT. 1994. Method for simultaneous isolation and quantitation of platelet activating factor and multiple arachidonate metabolites from small samples: analysis of effects of Staphylococcus aureus enterotoxin B in mice. Anal. Biochem. 216: 373.
30. FLESCHER, E., D. FOSSUM, P. J. GRAY, G FERNANDES, M. J. HARPER, and N. TALAL. 1991. Aspirin-like drugs prime human T cells. Modulation of intracellular calcium concentrations. J. Immunol. 146: 2553.
31. JUZAN, M., I. HOSTEIN, and N. GUALDE. 1992. Role of thymus-eicosanoids in the immune response. Prostaglandins Leukot. Essent. Fatty Acids 46: 247.
32. 2 upon differentiation and programmed cell death of suspension cultured CD4 CD8 thymocytes. Int. J. Immunopharmacol. 16: 775.
33. BROWN, D. M., G. L. WARNER, J. E. ALES-MARTINEZ, D. W. SCOTT, and R. P. PHIPPS. 1992. Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes. Clin. Immunol. Immunopathol. 63: 221.
34. KELLY, K., and K. A. KNOX. 1995. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD49. Cell. Immunol. 166: 93.
35. BROWN, D. M., and R. P. PHIPPS. 1996. Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas. J. Immunol. 157: 1359.
36. SANTOS-NETO, L., C. E. TOSTA, and J. G. DOREA. 1992. Zinc reverses the increased sensitivity of lymphocytes from aged subjects to the antiproliferative effect of prostaglandin E2. Clin. Immunol. Immunopathol. 64: 184.
37. SANTARPIA, G., M. VENZA, F. M. SALMERI, A. VALENTI, A. SOTTILE, and D. TETI. 1993. Impairment of lymphocyte sensitivity to prostaglandin E2 in cultures from patients with lymphoadenopathy associated syndrome. Ann. Clin. Lab. Sci. 23: 350.
38. BROWN, D. M., and R. P. PHIPPS. 1995. Characterization and regulation of prostaglandin E2 receptors on normal and malignant murine B lymphocytes. Cell. Immunol. 161: 79.
39. FEDYK, E. R., J. M. RIPPER, D. M. BROWN, and R. P. PHIPPS. 1996. A molecular analysis of PGE receptor (EP) expression on normal and transformed B lymphocytes: coexpression of EP1, EP2, EP3beta and EP4. Mol. Immunol. 33: 33.
40. BLASCHKE, V., K. JUNGERMANN, and G. P. PUSCHEL. 1996. Exclusive expression of the Gs-linked prostaglandin E2 receptor subtype 4 mRNA in mononuclear Jurkat and KM-3 cells and coexpression of subtype 4 and 2 mRNA in U-937 cells. FEBS Lett. 394: 39.
41. HOLTER, W., A. M. SPIEGEL, B. H. HOWARD, S. WEBER, and M. R. BRANN. 1991. Expression ot GTP-binding proteins and prostaglandin E2 receptors during human T cell activation. Cell. Immunol. 134: 287.
42. UOTILA, P. 1996. The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer. Cancer Immunol. Immunother. 43: 1.
43. CROLL, A. D., and A. G. MORRIS. 1986. The regulation of gamma-interferon production by interleukins 1 and 2. Cell. Immunol. 102: 33.
44. 2. Cell. Immunol. 138: 289.